While PD-L1 expression is widely recognized as a predictor of the immunotherapy response in many cancers, it is expressed at lower levels in SCLC patients and has not been identified as a crucial factor in the SCLC immunoptherapy response [145]. The gene discussed is CD274; the disease is small cell lung carcinoma.